UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000017172
Receipt number R000019925
Scientific Title Subtype classification of superficial esophageal cancer from gene expression profile
Date of disclosure of the study information 2015/04/19
Last modified on 2020/04/22 09:08:37

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Subtype classification of superficial esophageal cancer from gene expression profile

Acronym

Subtype classification of superficial esophageal cancer

Scientific Title

Subtype classification of superficial esophageal cancer from gene expression profile

Scientific Title:Acronym

Subtype classification of superficial esophageal cancer

Region

Japan


Condition

Condition

superficial esophageal cancer

Classification by specialty

Gastroenterology

Classification by malignancy

Malignancy

Genomic information

YES


Objectives

Narrative objectives1

To classify superficial esophageal cancer based on risk factors, endoscopic characteristics and gene expression of pretreatment biopsy sample

Basic objectives2

Others

Basic objectives -Others

prospective cohort study

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Subtype classification of superficial esophageal cancer based on gene expression profiles, risk factors and endoscopic characteristics

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1)Patients with superficial esophageal cancer who will undergo endoscopic resection, surgery or chemoradiotherapy
2)Squamous cell carcinoma
3)Written informed consent is obtained

Key exclusion criteria

1)Adenocarcinoma, small cell carcinoma or neuroendocrine carcinoma
2)Patients who have history of chemotherapy
3)Patients who have history of radiation therapy to the chest or mediastinum
4)Patients who have received antiplatelet agent or anticoagulation agent
5)Patients who have too small superficial esophageal cancer to take biopsy sample
6)Patient who are pregnant
7)Patients who have been judged as in appropriate for this study

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Ryu Ishihara

Organization

Osaka Medical Center for Cancer and Cardiovascular Diseases

Division name

Department of Gastrointestinal Oncology

Zip code


Address

1-3-3, Higashinari-ku, Osaka 537-8511, Japan

TEL

+81-6-6972-1181

Email

isihara-ry@mc.pref.osaka.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yasushi Yamasaki

Organization

Osaka Medical Center for Cancer and Cardiovascular Diseases

Division name

Department of Gastrointestinal Oncology

Zip code


Address

1-3-3, Higashinari-ku, Osaka 537-8511, Japan

TEL

+81-6-6972-1181

Homepage URL


Email

yamazaki-ya@mc.pref.osaka.jp


Sponsor or person

Institute

Osaka Medical Center for Cancer and Cardiovascular Diseases

Institute

Department

Personal name



Funding Source

Organization

Not yet confirmed

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor

National Cancer Center Research Institute

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

大阪府立成人病センター(大阪府)、国立がん研究センター研究所(東京都)


Other administrative information

Date of disclosure of the study information

2015 Year 04 Month 19 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2015 Year 03 Month 23 Day

Date of IRB

2015 Year 03 Month 23 Day

Anticipated trial start date

2015 Year 04 Month 20 Day

Last follow-up date

2021 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

prospective observational study


Management information

Registered date

2015 Year 04 Month 19 Day

Last modified on

2020 Year 04 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019925


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name